ÂÜÀòÂÒÂ×

David Browning is an accomplished leader in the healthcare sector with extensive experience in strategy and innovation. Currently serving as Chief Strategy Officer at EarSwitch, David focuses on transforming health monitoring through in-ear technology. As Managing Director of PARAGREEN ASSOCIATES LIMITED, David emphasizes precision medicine and proactive health. In the role of Entrepreneur in Residence at The Institute of Cancer Research, David mentors scientific innovators and advises on impactful strategies. David has held various leadership positions, including Chief Executive Officer at Fixed Phage and Oxford Cancer Biomarkers, where contributions included securing significant investments and establishing global partnerships. With a background in clinical biochemistry and marketing, David has a comprehensive educational foundation from multiple institutions, equipping him to drive advancements in healthcare and biosciences.